Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-26T11:14:36.989Z Has data issue: false hasContentIssue false
  • English
  • Français

Intranasal dexmedetomidine: the ideal drug for sedation in the pediatric echo lab?

Part of: Echocardiography

Published online by Cambridge University Press:  23 July 2021

David E Saudek Open the ORCID record for David E Saudek [Opens in a new window] ,
Deborah Walbergh ,
Peter Bartz ,
Sara Shreve ,
Amy Schaal ,
Julie Lavoie Open the ORCID record for Julie Lavoie [Opens in a new window]  and
Peter C Frommelt
David E Saudek*
Affiliation:
Medical College of Wisconsin, Milwaukee, Wisconsin, USA
Deborah Walbergh
Affiliation:
Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, USA
Peter Bartz
Affiliation:
Medical College of Wisconsin, Milwaukee, Wisconsin, USA
Sara Shreve
Affiliation:
Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, USA
Amy Schaal
Affiliation:
Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, USA
Julie Lavoie
Affiliation:
Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, USA
Peter C Frommelt
Affiliation:
Medical College of Wisconsin, Milwaukee, Wisconsin, USA
*
Author for correspondence: David Saudek, Children’s Wisconsin, 9000 W Wisconsin Ave, MilwaukeeWI 53226, USA. Tel/Fax: +1 (414) 266-2380. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Intranasal dexmedetomidine is an attractive option for procedural sedation in pediatrics due to ease of administration and its relatively short half-life. This study sought to compare the safety and efficacy of intranasal dexmedetomidine to a historical cohort of pediatric patients sedated using chloral hydrate in a pediatric echo lab.

Methods:

Chart review was performed to compare patients sedated between September, 2017 and October, 2019 using chloral hydrate and intranasal dexmedetomidine. Vital signs, time to sedation, duration of sedation, need for second dose of medication, rate of failed sedation, and impact on vital signs were compared between groups. Subgroup analysis was performed for those with complex and cyanotic heart disease.

Results:

Chloral hydrate was used in 356 patients and intranasal dexmedetomidine in 376. Patient age, complexity of heart disease, and duration of sedation were similar. Rates of failed sedation were very low and similar. Average heart rate and minimum heart rate were lower for those receiving intranasal dexmedetomidine than chloral hydrate. Impact on vital signs was similar for those with complex and cyanotic heart disease. No adverse events occurred in either group.

Conclusions:

Sedation with intranasal dexmedetomidine is comparable to chloral hydrate in regards to safety and efficacy for children requiring echocardiography. Consistent with the mechanism of action, patients receiving intranasal dexmedetomidine have a lower heart rate without morbidity.

Keywords

PediatricechocardiographyChloral hydratesedationdexmedetomidine
Type
Original Article
Information
Cardiology in the Young , Volume 32 , Issue 4 , April 2022 , pp. 545 - 549
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hill, GD, Walbergh, DB, Frommelt, PC. Efficacy of reconstituted oral chloral hydrate from crystals for echo sedation. J Am Soc Echocardiogr 2016; 29: 337–340. doi: 10.1016/j.echo.2015.11.014.CrossRefGoogle Scholar
Schwartz, LI, Twite, M, Gulack, B, Hill, K, Kim, S, Vener, DF. The perioperative use of dexmedetomidine in pediatric patients with congenital heart disease: an analysis from the Congenital Cardiac Anesthesia Society-Society of Thoracic Surgeons Congenital Heart Disease Database. Anesthesia-Analgesia 2016; 123: 715–721. doi: 10.1213/ANE.0000000000001314.CrossRefGoogle ScholarPubMed
Banasch, HL, Dersch-Mills, DA, Boulter, LL, Gilfoyle, E. Dexmedetomidine use in a pediatric intensive care unit: a retrospective cohort study Ann Pharmacother 2018; 52: 133–139. doi: 10.1177/1060028017734560.CrossRefGoogle Scholar
Cao, Q, Lin, Y, Xie, Z, et al. Comparison of sedation by intranasal dexmedetomidine and oral chloral hydrate for pediatric ophthalmic examination. Paediatr Anaesth 2017; 27: 629–636. doi: 10.1111/pan.13148.CrossRefGoogle ScholarPubMed
Olgun, G, Ali, MH. Use of intranasal dexmedetomidine as a solo sedative for MRI of infants. Hosp Pediatr 2018: 68–71. doi: 10.1542/hpeds.2017-0120.CrossRefGoogle ScholarPubMed
Li, BL, Zhang, N, Huang, JX, et al. A comparison of intranasal dexmedetomidine for sedation in children administered either by atomizer or by drops. Anaesthesia 2016; 71: 522–528. doi: 10.1111/anae.13407.CrossRefGoogle ScholarPubMed
Ramsay, MA, Savege, TM, Simpson, BR, Goodwin, R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2: 656–659. doi: 10.1136/bmj.2.5920.656.CrossRefGoogle ScholarPubMed
Whalen, LD, DiGennaro, JL, Irby, GA, Yanay, O, Zimmerman, JJ. Long-term dexmedetomidine use and safety profile among critically ill children and neonates. Pediatr Crit Care Med 2014; 15: 706–714. doi: 10.1097/PCC.0000000000000200.CrossRefGoogle ScholarPubMed
Hayden, JC, Doherty, DR, Dawkins, I, et al. The effectiveness of alpha-2 agonists as sedatives in pediatric critical care: a propensity score-matched cohort study. Crit Care Med 2019; 47: e580–e586. doi: 10.1097/CCM.0000000000003789.CrossRefGoogle ScholarPubMed
Hayden, JC, Breatnach, C, Doherty, DR, Healy, M, Gallagher, PJ, Cousins, G. Efficacy of alpha-2 agonists for sedation in pediatric critical care: a systematic review. Pediatr Crit Care Med 2016; 17: e66–e75. doi: 10.1136/bmjopen-2016-013858.CrossRefGoogle ScholarPubMed
Pan, W, Wang, Y, Lin, L, Zhou, G, Hua, X, Mo, L. Outcomes of dexmedetomidine treatment in pediatric patients undergoing congenital heart disease surgery: a meta-analysis. Paediatr Anesth 2016; 26: 239–248. doi: 10.1111/pan.12820.CrossRefGoogle ScholarPubMed
Sharma, K, Kumar, M, Gandhi, R. Effect of single-dose dexmedetomidine on intraoperative hemodynamics and postoperative recovery during pediatric adenotonsillectomy. Anesth Essays Res 2019; 13: 63–67. doi: 10.4103/aer.AER_178_18.Google ScholarPubMed
Poonai, N, Spohn, J, Vandermeer, B, et al. Intranasal dexmedetomidine for procedural distress in children: a systematic review. Pediatrics 2020; 145: e20191623. doi: 10.1542/peds.2019-1623.CrossRefGoogle ScholarPubMed
Miller, J, Xue, B, Hossain, M, Zhang, MZ, Loepke, A, Jurth, D. Comparison of dexmedetomidine and chloral hydrate sedation for transthoracic echocardiography in infants and toddlers: a randomized clinical trial. Paediatr Anaesth 2016; 26: 266–272. doi: 10.1111/pan.12819.CrossRefGoogle Scholar
Gu, HB, Song, YA, Bai, J. Median effective dose of intranasal dexmedetomidine for transthoracic echocardiography in children with Kawasaki Disease who have a history of repeated sedation. Med Sci Monit 2019; 25: 381–388. doi: 10.12659/MSM.912517.CrossRefGoogle ScholarPubMed
Fett, J, Hackbarth, R, Boville, BM, Olivero, AD, Davis, AT, Winters, JW. Comparative effectiveness of intranasal dexmedetomidine-midazolam versus oral chloral hydrate targeting moderate sedation during pediatric transthoracic echocardiograms. J Pediatr Intensive Care 2017; 6: 182–187. doi: 10.1055/s-0036-1597696.CrossRefGoogle ScholarPubMed
Tug, A, Hanci, A, Turk, HS, et al. Comparison of two different intranasal doses of dexmedetomidine in children for magnetic resonance imaging sedation. Paediatr Drugs 2015; 17: 479–485. doi: 10.1007/s40272-015-0145-1.CrossRefGoogle ScholarPubMed
Napoli, KL, Ingall, CG, Martin, GR. Safety and efficacy of chloral hydrate sedation in children undergoing echocardiography. J Pediatr 1996; 129: 287–291. doi: 10.1016/s0022-3476(96)70256-1.CrossRefGoogle ScholarPubMed